MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Isoray Operating Income 2011-2025 | ISR
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Isoray
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -90.9 M | -40.9 M | -5.62 M | -3.91 M | -3.48 M | -5.25 M | -6.73 M | -6.31 M | -5.08 M | -4.34 M | -4.59 M | -4.07 M | -3.6 M | -2.96 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.96 M | -90.9 M | -13.4 M |
Quarterly Operating Income Isoray
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27.9 M | -24 M | - | -18.6 M | -14.3 M | -13 M | - | -9.75 M | -9.75 M | -9.76 M | - | -4.21 M | -2.11 M | -1.38 M | -1.64 M | -2.27 M | -3.91 M | -766 K | -873 K | -714 K | -873 K | -714 K | -903 K | -836 K | -903 K | -836 K | -1.43 M | -1.52 M | -1.43 M | -1.52 M | -1.47 M | -1.55 M | -1.47 M | -1.55 M | -1.48 M | -1.58 M | -1.48 M | -1.58 M | -1.41 M | -1.09 M | -1.41 M | -1.09 M | -1.02 M | -1.16 M | -1.02 M | -1.16 M | -1.04 M | -1.23 M | -1.04 M | -1.23 M | -1.1 M | -1.12 M | -1.1 M | -1.12 M | -792 K | -1.1 M | -792 K | -1.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -714 K | -27.9 M | -3.46 M |
Operating Income of other stocks in the Medical instruments industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
14 M | $ 19.32 | 1.05 % | $ 9.85 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
2.58 B | $ 196.18 | -0.01 % | $ 56.4 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-10.5 M | $ 5.47 | -0.01 % | $ 110 M | USA |
 |
Harvard Bioscience
HBIO
|
1.89 M | $ 0.71 | -1.78 % | $ 30.1 M | USA |
 |
Alcon
ALC
|
580 M | $ 80.33 | 0.26 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
-10.3 M | $ 6.25 | -3.55 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
-116 M | $ 177.0 | 0.68 % | $ 5.52 B | USA |
 |
ICU Medical
ICUI
|
43 M | $ 148.17 | 0.81 % | $ 3.61 B | USA |
 |
LeMaitre Vascular
LMAT
|
52.3 M | $ 83.95 | -0.46 % | $ 1.88 B | USA |
 |
AtriCure
ATRC
|
-40 M | $ 40.7 | 0.37 % | $ 1.91 B | USA |
 |
Atrion Corporation
ATRI
|
22.6 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
-19.3 M | $ 4.93 | 1.54 % | $ 27.2 K | USA |
 |
AngioDynamics
ANGO
|
-40 M | $ 13.12 | -0.3 % | $ 536 M | USA |
 |
Merit Medical Systems
MMSI
|
156 M | $ 87.36 | -0.03 % | $ 5.09 B | USA |
 |
The Cooper Companies
COO
|
683 M | $ 82.55 | -0.03 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
-129 M | $ 116.08 | -0.56 % | $ 5.62 B | USA |
 |
Haemonetics Corporation
HAE
|
222 M | $ 80.39 | 0.36 % | $ 4.05 B | USA |
 |
InfuSystem Holdings
INFU
|
1.65 M | $ 8.93 | -1.71 % | $ 184 M | USA |
 |
Masimo Corporation
MASI
|
-267 M | $ 132.7 | -0.44 % | $ 7.07 B | USA |
 |
OraSure Technologies
OSUR
|
-28.2 M | $ 2.43 | - | $ 181 M | USA |
 |
Intuitive Surgical
ISRG
|
2.35 B | $ 578.08 | 0.16 % | $ 205 B | USA |
 |
Microbot Medical
MBOT
|
-9.86 M | $ 2.16 | -0.88 % | $ 22 M |  Israel |
 |
Milestone Scientific
MLSS
|
-6.76 M | $ 0.29 | -1.41 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
-1.59 M | $ 4.98 | -4.78 % | $ 51.7 M | USA |
 |
STERIS plc
STE
|
867 M | $ 255.64 | 0.02 % | $ 25.2 B | USA |
 |
NeuroMetrix
NURO
|
-8.78 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
-1.04 B | $ 21.99 | -0.05 % | $ 3.79 B | USA |
 |
Predictive Oncology
POAI
|
-10.9 M | - | - | $ 32.4 M | USA |
 |
Pro-Dex
PDEX
|
10.7 M | $ 39.33 | -2.65 % | $ 129 M | USA |
 |
Utah Medical Products
UTMD
|
16.8 M | $ 56.66 | 0.66 % | $ 206 M | USA |
 |
Pulse Biosciences
PLSE
|
-43.6 M | $ 14.45 | -2.76 % | $ 694 M | USA |
 |
ResMed
RMD
|
1 B | $ 245.14 | 0.3 % | $ 35.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-879 M | $ 11.47 | 3.66 % | $ 2.33 B | USA |
 |
Repligen Corporation
RGEN
|
47.7 M | $ 165.37 | -0.18 % | $ 9.21 M | USA |
 |
BioLife Solutions
BLFS
|
-7.13 M | $ 24.95 | -1.81 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
-21.8 M | $ 2.46 | 1.23 % | $ 199 M | USA |
 |
STAAR Surgical Company
STAA
|
-12.6 M | $ 23.37 | -1.1 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
-21.1 M | $ 0.82 | -0.51 % | $ 24.5 M | USA |
 |
Teleflex Incorporated
TFX
|
151 M | $ 122.75 | 0.7 % | $ 5.75 B | USA |
 |
West Pharmaceutical Services
WST
|
570 M | $ 274.28 | -0.95 % | $ 20 B | USA |